South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- After Ceuta: the youth bet
- Cameroon: Somdia sells its stake in SOSUCAM to a Cameroonian consortium, 210 million euros in investments announced
- BAD: Sidi Ould Tah initiates a profound reorganization of the African Development Bank
- Senegal: CDMP SA and FONAMIF mobilize 2 billion FCFA to refinance microfinance institutions
- Payment of the 2025 dividend of the African Rubber Plantation Company set for August 28, 2026
- Burkina Faso raises 49.5 billion CFA francs on the UEMOA financial market
- Morocco: How Akditalest became the coveted giant of private healthcare?
- Has a new path for water financing in Africa opened in N’Djamena?
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com